Transcriptional and post-transcriptional alterations of IκBα in active minimal-change nephrotic syndrome

Journal of the American Society of Nephrology

Volumn 12, Issue 8, 2001, Pages 1648-1658

  Sahali, D ^a   Pawlak, A ^a   Le Gouvello, S ^a   Lang, P ^a   Valanciute A ^a   Remy, P ^a   Loirat, C ^a   Niaudet, P ^a   Bensman, A ^a   Guellaen, G ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; PROTEIN P50; STEROID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME SUBUNIT; FEEDBACK SYSTEM; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEINURIA; RELAPSE; REMISSION;

EID: 0034911645     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Nephrotic syndrome in children
2. Treatment of childhood steroid-resistant idiopathic nephrotic syndrome
3. Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients
4. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome
5. Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats
6. The increase of memory T cell subsets in children with idiopathic nephrotic syndrome
7. T-lymphocyte subsets in nephrotic syndrome
8. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: Evidence for increased IL-13 mRNA expression in relapse
9. Increase of tumour necrosis factor a synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome
10. T-cell dysfunction in minimal-change nephrotic syndrome of childhood
11. IL-8 production by peripheral blood mononuclear cells in nephrotic patients
12. Structure, regulation and function of NF-κB
13. Expression of IκBα in the nucleus of human peripheral blood T lymphocytes
14. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα A mechanism for NF-κB activation
15. NF-κB controls expression of inhibitor IκBα. Evidence for an inducible autoregulatory pathway
16. Three NF-κB sites in the IκB-α promoter are required for induction of gene expression by TNF α
17. The primary nephrotic syndrome in children: Identification of patients with minimal change nephrotic syndrome from initial response to prednisone: A report of the international study of kidney disease in children
18. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
19. Transcription-independent turnover of IκBα during monocyte adherence: Implications for a translational component regulating IκBα/MAD-3 mRNA levels
20. Defective IκBα in Hodgkin cell lines with constitutively active NF-κB
21. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting
22. Mechanisms of proteinuria in noninflammatory glomerular diseases
23. Messenger RNA degradation in eukaryotes
24. Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a < 20S degradation complex
25. Control of mRNA decay by heat shock-ubiquitin-proteasome pathway
26. Cytokine modulation by glucocorticoids: Mechanisms and actions in cellular studies
27. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase
28. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor
29. Negative cross-talk between Re1A and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids
30. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis
31. Analysis of proteins that interact with IL-2 regulatory region in patients with rheumatic diseases
32. Abnormal NF-κB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-Re1A protein expression
33. Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells